Sunshine in US, home glow to help Sun Pharma beat industry show

October 29, 2024

The India business, accounting for a third of the company’s total revenues, grew at 11%. This is a volume-led growth aided by new product launches. Sun’s India business grew higher than the Indian Pharma market growth. The company launched 14 new products during the quarter.

More To Explore

Bharti Hexacom shares zoom 4% after Q3 PAT, revenue jump over 20% YoY

Bharti Hexacom shares rose 3.8% after the company reported a 23% increase in net profit, reaching Rs 261 crore, and a 25% rise in revenue

February 7, 2025

Trent shares jump 2% after Q3 profit jumps 33% YoY. Should you buy, sell, or hold?

Trent’s shares rose nearly 2% as Q3 FY25 net profit grew 33% to Rs 497 crore. Revenue increased by 34% to Rs 4,657 crore. The

February 7, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003